Background: We provide here direct comparison of viral load in nasopharyngeal specimens of patients infected by Omicron and former severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Methods: We retrospectively reviewed the results of SARS-CoV-2 testing conducted during two corresponding periods of years 2021 and 2022 (i.e., between 3-9 January), characterized by local prevalence of Alpha (>95%; January 2021) and Omicron (>90%; January 2022) SARS-CoV-2 variants, respectively. In both years viral load was quantified using the same method and instrumentation (Seegene Allplex SARS-CoV-2 Assay). Results: The total number of patients with positive SARS-CoV-2 tests was 47 in January 2021 and 118 in January 2022, respectively. The cycle threshold (Ct) values in January 2022 (median Ct value, 27.5; IQR, 23.5-32.7) when the Omicron variant was prevalent were significantly lower than those measured during the same period of the year 2021 (median Ct value, 31.8; IQR, 26.4-37.6; p=0.007), when the Alpha variant was prevalent. The rate of subjects with high nasopharyngeal viral load was over 2-fold higher in January 2022 than in January 2021 (45/118 vs. 10/47; Odds ratio, 2.28 and 95%CI, 1.03-5.03; p=0.041). Conclusions: These results support the suggestion that aerosols released by patients infected by SARS-CoV-2 Omicron variant may contain higher viral particles than those released by subjects infected with previous strains.

SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load

Salvagno, Gian Luca;Pighi, Laura;De Nitto, Simone;Montagnana, Martina;Lippi, Giuseppe
2022

Abstract

Background: We provide here direct comparison of viral load in nasopharyngeal specimens of patients infected by Omicron and former severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Methods: We retrospectively reviewed the results of SARS-CoV-2 testing conducted during two corresponding periods of years 2021 and 2022 (i.e., between 3-9 January), characterized by local prevalence of Alpha (>95%; January 2021) and Omicron (>90%; January 2022) SARS-CoV-2 variants, respectively. In both years viral load was quantified using the same method and instrumentation (Seegene Allplex SARS-CoV-2 Assay). Results: The total number of patients with positive SARS-CoV-2 tests was 47 in January 2021 and 118 in January 2022, respectively. The cycle threshold (Ct) values in January 2022 (median Ct value, 27.5; IQR, 23.5-32.7) when the Omicron variant was prevalent were significantly lower than those measured during the same period of the year 2021 (median Ct value, 31.8; IQR, 26.4-37.6; p=0.007), when the Alpha variant was prevalent. The rate of subjects with high nasopharyngeal viral load was over 2-fold higher in January 2022 than in January 2021 (45/118 vs. 10/47; Odds ratio, 2.28 and 95%CI, 1.03-5.03; p=0.041). Conclusions: These results support the suggestion that aerosols released by patients infected by SARS-CoV-2 Omicron variant may contain higher viral particles than those released by subjects infected with previous strains.
COVID-19, Infectivity, Omicron, SARS-CoV-2, Viral load
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/1058695
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact